Q1 2025 EPS Estimates for DocuSign, Inc. Raised by Zacks Research (NASDAQ:DOCU)

DocuSign, Inc. (NASDAQ:DOCU) – Stock analysts at Zacks Research increased their Q1 2025 earnings per share (EPS) estimates for shares of DocuSign in a research report issued to clients and investors on Wednesday, April 24th. Zacks Research analyst R. Department now forecasts that the company will earn $0.22 per share for the quarter, up from their previous forecast of $0.19. The consensus estimate for DocuSign’s current full-year earnings is $0.87 per share. Zacks Research also issued estimates for DocuSign’s Q2 2025 earnings at $0.16 EPS, Q3 2025 earnings at $0.18 EPS, Q4 2025 earnings at $0.18 EPS, FY2025 earnings at $0.76 EPS, Q1 2026 earnings at $0.23 EPS, Q2 2026 earnings at $0.16 EPS, Q3 2026 earnings at $0.20 EPS, Q4 2026 earnings at $0.16 EPS, FY2026 earnings at $0.77 EPS and FY2027 earnings at $0.75 EPS.

DocuSign (NASDAQ:DOCU) last released its quarterly earnings results on Thursday, March 7th. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.06. DocuSign had a net margin of 2.68% and a return on equity of 13.91%. The business had revenue of $712.39 million for the quarter, compared to analysts’ expectations of $698.05 million.

Several other research analysts also recently issued reports on the stock. JMP Securities reiterated a “market outperform” rating and issued a $84.00 target price on shares of DocuSign in a research note on Friday, April 12th. UBS Group upgraded DocuSign from a “sell” rating to a “neutral” rating and increased their target price for the company from $48.00 to $62.00 in a research note on Friday, April 12th. Morgan Stanley raised DocuSign from an “underweight” rating to an “equal weight” rating and lifted their target price for the stock from $49.00 to $64.00 in a report on Tuesday, January 16th. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a report on Friday, April 12th. Finally, Wells Fargo & Company dropped their price objective on DocuSign from $55.00 to $45.00 and set an “underweight” rating on the stock in a research report on Monday, February 5th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $60.25.

DocuSign Trading Down 0.3 %

DOCU opened at $57.20 on Friday. The company has a market cap of $11.75 billion, a price-to-earnings ratio of 158.89, a price-to-earnings-growth ratio of 4.96 and a beta of 0.89. The stock has a fifty day simple moving average of $56.49 and a two-hundred day simple moving average of $52.72. DocuSign has a 12-month low of $38.11 and a 12-month high of $64.76.

Institutional Trading of DocuSign

Several institutional investors and hedge funds have recently bought and sold shares of DOCU. Vanguard Group Inc. lifted its position in DocuSign by 2.0% during the fourth quarter. Vanguard Group Inc. now owns 21,399,739 shares of the company’s stock valued at $1,272,214,000 after purchasing an additional 417,352 shares during the period. Coatue Management LLC acquired a new position in shares of DocuSign in the 4th quarter valued at about $288,274,000. Clearbridge Investments LLC boosted its stake in shares of DocuSign by 4.6% in the fourth quarter. Clearbridge Investments LLC now owns 2,643,464 shares of the company’s stock worth $157,154,000 after buying an additional 116,128 shares during the last quarter. Norges Bank acquired a new stake in DocuSign during the fourth quarter worth about $133,826,000. Finally, AQR Capital Management LLC grew its holdings in DocuSign by 147.4% during the third quarter. AQR Capital Management LLC now owns 1,908,500 shares of the company’s stock worth $80,157,000 after acquiring an additional 1,136,948 shares during the period. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO Allan C. Thygesen sold 7,680 shares of DocuSign stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $61.27, for a total transaction of $470,553.60. Following the completion of the sale, the chief executive officer now owns 111,767 shares of the company’s stock, valued at $6,847,964.09. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other DocuSign news, Director Teresa Briggs sold 499 shares of the stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $52.99, for a total transaction of $26,442.01. Following the completion of the sale, the director now directly owns 6,169 shares of the company’s stock, valued at $326,895.31. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Allan C. Thygesen sold 7,680 shares of DocuSign stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $61.27, for a total transaction of $470,553.60. Following the completion of the transaction, the chief executive officer now directly owns 111,767 shares in the company, valued at $6,847,964.09. The disclosure for this sale can be found here. In the last three months, insiders sold 54,871 shares of company stock valued at $3,176,199. Insiders own 17.80% of the company’s stock.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.